When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MLLCF - FDA rejects Allergan application for wet AMD drug
Molecular Partners AG
AbbVie (NYSE:ABBV) unit Allergan has received a Complete Response Letter (CRL) from the FDA regarding its marketing application seeking approval of DARPin drug abicipar pegol for the treatment of neovascular age-related macular degeneration (wet AMD).
More news on: AbbVie Inc., Molecular Partners AG, Regeneron Pharmaceuticals, Inc., Healthcare stocks news,